South Africa Monitors New Covid-19 Variant as Global Partners Rally Behind WHO Pandemic Agreement

Strategic Insights -

South African Health Minister Aaron Motsoaledi briefed the G20 Health Working Group on the emergence of a new Covid-19 variant, Nimbus or NB.1.8.1, which shares a lineage with Omicron but is not considered a cause for concern due to the effectiveness of current vaccines. The variant is being closely monitored, but current data shows low SARS-CoV-2 activity, with a seasonal increase in influenza cases under control. Motsoaledi praised the recent adoption of the World Health Organization (WHO) Pandemic Agreement and called for global partners to support its implementation, highlighting the agreement's key pillars for reshaping the approach to global health emergencies.

Key Takeaways:

  • The new Covid-19 variant, Nimbus or NB.1.8.1, is a descendant of the Omicron lineage, and current vaccine recommendations remain effective.
  • South Africa has robust surveillance systems in place, with the National Institute for Communicable Diseases managing a comprehensive sentinel surveillance program for SARS-CoV-2, influenza, and RSV.
  • The Health Department will continue to monitor the situation and report any significant changes.
  • Motsoaledi called for elevated political will from G20 members and global partners to overcome commercial and diplomatic hurdles in implementing the WHO Pandemic Agreement.
  • The agreement sets out principles, approaches, and tools for better international coordination in pandemic prevention and response, including equitable access to vaccines, therapeutics, and diagnostics.
  • The agreement's Pathogen Access and Benefit-Sharing (PABS) system will require pharmaceutical manufacturers to contribute 20% of their production during pandemic emergencies in return for access to pathogen data.
  • The detailed negotiations on the PABS system annexure will commence through an intergovernmental working group, with a first meeting to elect the bureau before 15 July.

Sources:

  • G20 Health Working Group
  • World Health Organization Pandemic Agreement
  • South African Department of Health
  • Daily Maverick article

Statistics:

  • 20%: The percentage of production that pharmaceutical manufacturers will contribute under the Pathogen Access and Benefit-Sharing (PABS) system.
  • 15 July: The deadline for the first meeting of the intergovernmental working group to elect the bureau for the PABS system negotiations.
  • Over three years: The duration of intensive negotiations by governments in response to the Covid-19 pandemic that led to the adoption of the WHO Pandemic Agreement.
  • 78th World Health Assembly: The assembly that formally adopted the WHO Pandemic Agreement in May.